Journal article
S100A1 Expression in Ovarian and Endometrial Endometrioid Carcinomas Is a Prognostic Indicator of Relapse-Free Survival
Abstract
We sought to investigate the expression levels of S100A1 in ovarian cancer cell lines and tissues to correlate S100A1 with subtype, stage, grade, and relapse-free survival. S100A1 messenger RNA and protein were up-regulated in ovarian cancer cell lines and tumors compared with normal ovarian cell lines and tissues by gene microarray analysis, reverse transcriptase-polymerase chain reaction, quantitative reverse transcriptase-polymerase chain …
Authors
DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KLM; Argenta PA; Skubitz APN
Journal
American Journal of Clinical Pathology, Vol. 132, No. 6, pp. 846–856
Publisher
Oxford University Press (OUP)
Publication Date
December 1, 2009
DOI
10.1309/ajcptk87emmikpfs
ISSN
0002-9173
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overBiomarkers, TumorBlotting, WesternCarcinoma, EndometrioidDisease-Free SurvivalEndometrial NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansImmunohistochemistryMiddle AgedNeoplasm StagingOligonucleotide Array Sequence AnalysisOvarian NeoplasmsPrognosisRNA, MessengerS100 ProteinsSurvival RateTissue Array Analysis